Claim: Overexpression of BMI1 appears to play a role in several types of cancer; and inhibiting BMI1 may reduce certain types of cancers.
Evidence: Overexpression of Bmi1 seems to play an important role in several types of cancer, such as bladder, skin, prostate, breast, ovarian, colorectal as well as hematological malignancies. Inhibiting BMI1 has been shown to inhibit the proliferation of glioblastoma multiforme, chemoresistant ovarian cancer, prostatic, pancreatic and skin cancers.